Codexis Inc (CDXS, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels. Codexis Inc has a market cap of $1.13 billion; its shares were traded at around $20.91 with and P/S ratio of 15.94. Codexis Inc had annual average EBITDA growth of 20.80% over the past five years.
For the last quarter Codexis Inc reported a revenue of $16.1 million, compared with the revenue of $21.72 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $60.6 million, an increase of 21.1% from last year. For the last five years Codexis Inc had an average revenue growth rate of 13.4% a year.
The reported loss per diluted share was 21 cents for the year, compared with the loss per share of $0.5 in the previous year. The Codexis Inc had an operating margin of -18.64%, compared with the operating margin of -45.92% a year before. The 10-year historical median operating margin of Codexis Inc is -28.36%. The profitability rank of the company is 3 (out of 10).
At the end of the fiscal year, Codexis Inc has the cash and cash equivalents of $53.0 million, compared with $31.2 million in the previous year. The long term debt was $0.06 million, compared with $0.30 million in the previous year. Codexis Inc has a financial strength rank of 8 (out of 10).
At the current stock price of $20.91, Codexis Inc is traded at 426.7% premium to its historical median P/S valuation band of $3.97. The P/S ratio of the stock is 15.94, while the historical median P/S ratio is 3.02. The stock gained 118.95% during the past 12 months.
Directors and Officers Recent Trades:
- Director Dennis P Wolf sold 9,000 shares of CDXS stock on 02/26/2019 at the average price of $21.96. The price of the stock has decreased by 4.78% since.
- SVP, R&D James Lalonde sold 17,915 shares of CDXS stock on 02/12/2019 at the average price of $21.63. The price of the stock has decreased by 3.33% since.
For the complete 20-year historical financial data of CDXS, click here.
